<DOC>
	<DOCNO>NCT01453686</DOCNO>
	<brief_summary>The use topical steroid treatment alopecia areata child common practice . However , particular potency steroid accept standard treatment due paucity high quality evidence dermatology literature substantiate use . Two randomize control trial exist assess topical steroid efficacy disorder , methodological limitation . The question remain topical steroid safe efficacious use . We perform double blind control trial ass usefulness class 1 topical steroid ( clobestasol proprionate 0.05 % ) compare class 7 topical steroid ( hydrocortisone 1 % ) child alopecia areata .</brief_summary>
	<brief_title>A Trial Clobetasol Propionate Versus Hydrocortisone Children With Alopecia Areata</brief_title>
	<detailed_description />
	<mesh_term>Alopecia</mesh_term>
	<mesh_term>Alopecia Areata</mesh_term>
	<mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
	<mesh_term>Cortisol succinate</mesh_term>
	<mesh_term>Hydrocortisone acetate</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<mesh_term>Clobetasol</mesh_term>
	<criteria>Age 2 16 year New patient present The Hospital Sick Children Clinical confirmation alopecia areata Hair loss 10 75 % Skin medical problem require use oral steroid Immunosuppressants PUVA 4 week prior study Use inhale intranasal steroid 14 day prior trial Topical medicament 7 day prior trial</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Alopecia Areata</keyword>
	<keyword>Hydrocortisone</keyword>
	<keyword>Clobetasol Propionate</keyword>
	<keyword>Randomized Controlled Trial</keyword>
</DOC>